WHAT IS THE WORLD IMMUNOTHERAPY CONGRESS?

Networking


It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
 

 

FIND OUT MORE

Conference


The World Immunotherapy Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

 

FIND OUT MORE

Exhibition

Exhibit


This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.

 

FIND OUT MORE


Co-located with

 

World Biosimilar congress

European Antibody Congress

HPAPI World Congress

Part of

 

Festival of Biologics

2018 Advisory Board

The agenda is being shaped by an industry advisory board, with members including:

 

Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Dario Neri

Founder, Philogen;
Professor of Chemistry & Applied Biology
Swiss Federal Institute of Technology Zurich

Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Roy Baynes

SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

M. Anthony Moody, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
M. Anthony Moody

Associate Professor, Department of Paediatrics, Division of Infectious Diseases
Duke University Medical Centre

Frédéric Triebel, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Frédéric Triebel

Chief Scientific Officer, Chief Medical Officer
Prima BioMed

Shane Olwill, Head of Immuno-Oncology, Pieris Pharmaceuticals
Shane Olwill

Head of Immuno-Oncology
Pieris Pharmaceuticals

Alain Vertes, Managing Director, NxR Biotechnologies
Alain Vertes

Managing Director
NxR Biotechnologies

Ahuva Nissim, Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Ahuva Nissim

Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology
William Harvey Research Institute, Queen Mary University

 

Joern Schmitz, Head, Department of Immunotherapy, Fraunhofer IME
Joern Schmitz

Head, Department of Immunotherapy
Fraunhofer IME

"Great depth and variety with engaging open discussions across industry/academic and biotech."


Biomarker Development Specialist, Cancer Research U.K. Cambridge Institute

World Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy Congress

Past Key Speakers include

 

  • Dr Rafael Amado at World Immunotherapy Congress
    Dr Rafael Amado
    Chief Medical Officer
    Adaptimmune
    Prof Steve Anderton at World Immunotherapy Congress
    Prof Steve Anderton
    Chief Scientific Officer
    Aquila BioMedical
  • Dr Renier Brentjens at World Immunotherapy Congress
    Dr Renier Brentjens
    Director, Cellular Therapeutics
    Memorial Sloan-Kettering Cancer Center
    Martina Canestraro at World Immunotherapy Congress
    Martina Canestraro
    Senior Research Scientist
    Immunocore Ltd
  • Dr Seth Ettenberg at World Immunotherapy Congress
    Dr Seth Ettenberg
    Chief Scientific Officer
    Unum Therapeutics Inc.
    Dr Jim Freeth at World Immunotherapy Congress
    Dr Jim Freeth
    Managing Director
    Retrogenix
  • Dr David Gilham at World Immunotherapy Congress
    Dr David Gilham
    Vice President of Research and Development
    Celyad
    Professor Robert Hawkins at World Immunotherapy Congress
    Professor Robert Hawkins
    CEO and Co-founder
    Cellular Therapeutics Ltd
  • Dr Karin Jooss at World Immunotherapy Congress
    Dr Karin Jooss
    Executive Vice President of Research, and Chief Scientific Officer
    Gritstone Oncology
    Dr Milena Kalaitsidou at World Immunotherapy Congress
    Dr Milena Kalaitsidou
    Post Doctoral Research Associate (University of Manchester)
    GSK
  • Dr Sidath Katugampola at World Immunotherapy Congress
    Dr Sidath Katugampola
    Biomarker Development Specialist
    Cancer Research U.K. Cambridge Institute
    Dr Christian Klein at World Immunotherapy Congress
    Dr Christian Klein
    Head Oncology Programs
    Roche Pharmaceutical Research and Early Development
  • Dr James Legg at World Immunotherapy Congress
    Dr James Legg
    Vice President, Research and Development
    Crescendo Biologics Ltd
    Prof Dr Dario Neri at World Immunotherapy Congress
    Prof Dr Dario Neri
    Co-founder, Philogen; Department of Chemistry and Applied Biosciences
    Swiss Federal Institute of Technology Zurich
  • Dr Shane Olwill at World Immunotherapy Congress
    Dr Shane Olwill
    Vice President of Development
    Pieris Pharmaceuticals
    Dr Angie Inkyung Park at World Immunotherapy Congress
    Dr Angie Inkyung Park
    Sr. Director of Immunotherapy and Stem Cells
    Oncomed Pharmaceuticals
  • Sari Pesonen at World Immunotherapy Congress
    Sari Pesonen
    VP Scientific and Clinical Development, Co-Founder
    Valo Therapeutics
    Laurent Poirot at World Immunotherapy Congress
    Laurent Poirot
    Head of Early Discovery
    Cellectis
  • Dr Alfonso Quintas at World Immunotherapy Congress
    Dr Alfonso Quintas
    Head of Clinical Development, Cell Therapy
    GSK
    Dr Jose Saro at World Immunotherapy Congress
    Dr Jose Saro
    T.M.L. Pharma Research and Early Development, Oncology
    Roche
  • Jae Sly at World Immunotherapy Congress
    Jae Sly
    Director of Strategic Business Development
    ACRO Biosystems Inc
    Dr James Smith at World Immunotherapy Congress
    Dr James Smith
    Research Associate
    C.A.S.M.I. University of Oxford
  • Dr Martin Treder at World Immunotherapy Congress
    Dr Martin Treder
    Chief Scientific Officer
    Affimed Therapeutics Ag
    Dr Frédéric Triebel at World Immunotherapy Congress
    Dr Frédéric Triebel
    Chief Scientific Officer and Medical Officer
    Prima Biomed, Ltd
  • Peter Ulrich at World Immunotherapy Congress
    Peter Ulrich
    Safety Assessment Expert
    Novartis Institutes for Biomedical Research
    Dr Timo Van Den Berg at World Immunotherapy Congress
    Dr Timo Van Den Berg
    Professor of Immunotherapy, Head of Department of Blood Cell Research
    Sanquin Research and Landsteiner Laboratory
  • Dr Martin Welschof at World Immunotherapy Congress
    Dr Martin Welschof
    Chief Executive Officer
    Opsona Therapeutics Ltd

 

SEE MORE SPEAKERS

Who Attends

 

AbbVie     Abzena     ADC Therapeutics     Alligator Bioscience     Amgen     AstraZeneca     Biogen     Biosim Spanish Association of Biosimilars     Boehringer Ingelheim     Bristol Myers Squibb     Cancer Research UK     Cinfa Biotech GmbH     Dr. Reddy's Laboratories SA.     Duke University Medical Centre     Eli Lilly & Co     European Molecular Biology Laboratory     European Patent Office     European Specialist Nurses Organisations     Ferrer International     Fraunhofer IME     Gedeon Richter     Goldstein & Fox     GSK     HPAPI Project Services Ltd     Janssen     Libbs Pharmaceutica     Lonza     mAbs     Macrogenics     Maverick Therapeutics     MedImmune     Merck     Merck, Sharp & Dohme (MSD)     Napp pharmaceuticals     NAPP Pharmaceuticals     NBE Therapeutics     NHS     NIBR     NICE     NIHR Clinical Research Network (NIHR CRN)     Norwegian Medicines Agency     Novartis     NovImmune     NxR Biotechnologies     Opsona Therapeutics     Oril Industrie     Ossianix     PAREXEL     Paul Ehrlich Institute     Pfizer Biotherapeutics     Pieris Pharmaceuticals     Pierre Fabre     Prima BioMed     Roche     Roche     S.A.Toral      SafeBridge       Sandoz Biopharmaceuticals     Sandoz      Sanofi     Sanofi R&D     Sanquin     Seattle Genetics     Technische Universität Braunschweig     Teva Pharmaceuticals     The Royal Marsden NHS Foundation Trust     Therapeomic     TU Wien     UCB Celltech     University of Cambridge     University of Denmark      University of Messina – Italy     University of Stuttgart

 

FIND OUT MORE

Sponsors & Exhibitors

 

  • Exhibitor

    Anaquant Biologics and Biomarkers Analyses at World Immunotherapy Congress

    Partner

    Canton of Basel-Stadt at World Immunotherapy Congress

    Exhibitor

    imAb at World Immunotherapy Congress
  • Associate

    Infors at World Immunotherapy Congress

    Associate

    Pepscan Presto BV at World Immunotherapy Congress

    Exhibitor

    Proteo Genix at World Immunotherapy Congress
  • Associate

    Sterne Kessler Goldstein And Fox Plc at World Immunotherapy Congress

    Gold Sponsor

    Fujifilm Diosynth Biotechnologies at World Immunotherapy Congress

    Gold Sponsor

    KBI Biopharma at World Immunotherapy Congress
  • Gold Sponsor

    MabDesign at World Immunotherapy Congress

    Silver Sponsor

    ACRO Biosystems Inc at World Immunotherapy Congress

    Silver Sponsor

    Icosagen Cell Factory OU at World Immunotherapy Congress
  • Silver Sponsor

    Isogenica Ltd at World Immunotherapy Congress

    Silver Sponsor

    MaxCyte at World Immunotherapy Congress

    Silver Sponsor

    Sartorius Corporate Administration GmbH at World Immunotherapy Congress
  • Silver Sponsor

    Schrödinger at World Immunotherapy Congress

    Associate Sponsor

    AbCheck at World Immunotherapy Congress

    Associate Sponsor

    Abzena at World Immunotherapy Congress
  • Associate Sponsor

    Axinn at World Immunotherapy Congress

    Associate Sponsor

    Bioreclamationivt at World Immunotherapy Congress

    Associate

    Dynamic Biosensors at World Immunotherapy Congress
  • Associate Sponsor

    Food Pharma Systems at World Immunotherapy Congress

    Associate Sponsor

    Immatics Biotechnologies GmbH at World Immunotherapy Congress

    Associate Sponsor

    Lonza at World Immunotherapy Congress
  • Exhibitor

    Adolf Kuhner Ag at World Immunotherapy Congress

    Exhibitor

    Axenis at World Immunotherapy Congress

    Exhibitor

    Evidentic GmbH at World Immunotherapy Congress
  • Exhibitor

    MAbSilico at World Immunotherapy Congress

    Exhibitor

    MI-mAbs at World Immunotherapy Congress

    Exhibitor

    MUNIT at World Immunotherapy Congress
  • Exhibitor

    PX Therapeutics at World Immunotherapy Congress

    Exhibitor

    R.D. Biotech at World Immunotherapy Congress

    Exhibitor

    Aldevron at World Immunotherapy Congress
  • Exhibitor

    BioRad at World Immunotherapy Congress

    Exhibitor

    Bio-Techne at World Immunotherapy Congress

    Exhibitor

    CitoxLab Atlanbio at World Immunotherapy Congress
  • Exhibitor

    DiscoverX Corporation Ltd at World Immunotherapy Congress

    Exhibitor

    EasyChelators SAS at World Immunotherapy Congress

    Exhibitor

    Envigo at World Immunotherapy Congress
  • Exhibitor

    Groupe NOVASEP at World Immunotherapy Congress

    Exhibitor

    I and L Biosystems at World Immunotherapy Congress

    Exhibitor

    MInakem High Potent at World Immunotherapy Congress
  • Exhibitor

    Quality Assistance S.A. at World Immunotherapy Congress

 

SPONSORSHIP OPPORTUNITIES


Put your company at the forefront of the immunotherapy community and sponsor the World Immunotherapy Congress.

Download the prospectus to see how you can get involved.

 

DOWNLOAD PROSPECTUS

See you in Basel  |  29th - 31st October

 

 

REGISTER NOW

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates